You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

9 Results
Guidelines and Advice
Status: Current
ID: MCC
Jun 2006
Drug
Drug
Other Name(s): Rydapt®
Jun 2022
Regimen
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Neoadjuvant, Adjuvant, Palliative
Sep 2022
Regimen
Intent: Palliative
Nov 2022
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Apr 2022
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade
Intent: Curative
Jun 2022